Google-backed Fitbit AI health coach to access medical records soon

Google is rolling out a preview that lets U.S. Fitbit users link electronic medical records directly to the wearable’s AI health coach, a move aimed at sharpening the assistant’s recommendations with clinical context. According to a blog post by Fitbit health‑intelligence product‑management director Florence Thng, the integration will pull lab results, medication lists, and visit histories into the same data stream that already powers activity, heart‑rate, and sleep metrics. The combined view enables the coach to answer queries such as “How can I improve my cholesterol?” by summarizing recent lipid panels, flagging trends, and tailoring lifestyle tips to the user’s documented health profile. Google emphasizes that the feature is “securely shareable” via link or QR code, allowing users to forward AI‑generated summaries to family members or clinicians, but it does not permit the coach to diagnose, treat, or monitor disease (The Verge).

The rollout is part of what Google describes as Fitbit’s “most significant update yet” to its sleep‑tracking algorithms, which it claims will be 15 percent more accurate and better at distinguishing true sleep from time spent in bed trying to fall asleep. Those improvements will appear in the same preview window as the medical‑record capability, with an enhanced sleep score slated for release in the weeks that follow. By pairing higher‑fidelity sleep data with clinical records, Google hopes to deliver advice that is both “safer, more relevant and more personalized,” according to Thng’s statement (The Verge).

Google’s strategy mirrors a broader industry push to monetize health‑focused AI by leveraging users’ most sensitive data. Competitors such as Amazon, OpenAI, and Microsoft have already encouraged users to feed medical information into their conversational agents, betting that the promise of hyper‑personalized guidance outweighs privacy concerns. Fitbit’s approach differs in that it explicitly bars the AI from any diagnostic function, a disclaimer echoed in the blog’s fine print: “Fitbit is not intended to use your medical records to diagnose, treat, cure, prevent, or monitor any disease or condition,” and users are urged to consult a professional before acting on any advice (The Verge). The company also reiterates that health data will not be used for advertising and that users retain full control over storage, sharing, and deletion.

Regulatory scrutiny remains a key risk as consumer‑grade AI health tools blur the line between wellness advice and medical advice. Analysts have warned that even well‑intentioned summarization features could trigger oversight from the U.S. Food and Drug Administration if the output is perceived as a clinical recommendation. While Google has not disclosed any formal engagement with regulators, the company’s public commitment to data control and its explicit non‑diagnostic positioning suggest an effort to stay within the current “wellness” classification rather than crossing into regulated medical device territory (The Verge). Nevertheless, the move raises questions about liability and the adequacy of consent mechanisms when users grant a fitness app access to comprehensive health histories.

The integration also signals a shift in Fitbit’s product roadmap toward a more holistic health platform rather than a pure activity tracker. By unifying wearable sensor streams with electronic health records, Google is positioning Fitbit as a personal health hub that can compete with dedicated health‑tech startups such as Oura and Woop, which already employ chatbot‑driven coaching. Unlike Anthropic’s Claude or OpenAI’s ChatGPT, which openly invite users to discuss medical data, Google has kept its Gemini‑powered coach’s health capabilities under tighter internal control, perhaps to mitigate the regulatory exposure noted above. If the preview proves popular, the feature could become a differentiator for Fitbit in a crowded market, but its success will hinge on user trust in Google’s data‑handling promises and on the industry’s evolving stance toward AI‑augmented health advice.